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ELECTRIC TOOTHBRUSH
USP 6,178,579 B1; Jan. 30, 2001; Nottingham, Spirk, 
Blaustein, Osher, and Gall
Patent Abstract
An electric toothbrush comprising an elongated body 
portion and a head including a static portion and a circular 
portion, a handle, and an angled shaft between the head and 
the handle. The circular portion rotates or reciprocates about 
an axis normal to a longitudinal axis of the head. The circular 
portion includes stiff bristles, and the static portion includes 
soft bristles. The elongated body portion is hollow and further 
includes a motor in the hollow portion, which is operatively 
connected to the circular portion for rotating or oscillating or 
reciprocating the circular portion. A battery is located within the 
hollow section for powering the motor. A switch is operatively 
connected to the motor to provide momentary and continuous 
operation of the toothbrush. A worm gear and a pair of step 
gears are located in the hollow portion. The motor is operatively 
connected to the worm gear, and the step gears are operatively 
connected to the worm gear and to each other. One of the 
step gears is offset with respect to a longitudinal axis of the 
elongated body portion. A shaft is operatively connected to 
the offset step gear and to a second end to the circular portion. 
Alternately, the toothbrush comprises a plurality of gears and 
swivel arms which move the brush head moving portion in a 
rotating, oscillating, or reciprocating manner.
Inventors John R. Nottingham, John W. Spirk, 
and Attorney Patrick Roche
2012 Ohio Patent Impact Award
American consumers have been told for years that electric toothbrushes do a better job than manual ones in removing foods that cause 
cavities and gum disease. Yet the high cost of electric 
toothbrushes made that a pie-in-the-sky proposition 
for most households. The Spinbrush—more of a 
technological breakthrough than a scientific discovery 
—changed all that in 2001 with a $5 appliance priced 
within dollars of its manual competitors.
That year, John Nottingham and John Spirk of 
Nottingham Spirk Design Associates in Cleveland 
secured a patent on an ergonomic, oscillating brush 
design that sold 40 million units and earned Proctor 
& Gamble’s Crest brand $120 million in 2001 alone. 
With legal expertise from attorney Patrick Roche of 
intellectual property firm Fay Sharpe LLP, the budget-
minded toothbrush went on to earn all three the Ohio 
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Academy Science and the Ohio State Bar Association’s 
OSBA Ohio Impact Patent Award for 2012.
Until the Spinbrush, electric toothbrushes priced 
around $100 had attracted only 1 percent of the dental 
market. Introduced in Europe as an AC-powered 
appliance in 1954, the Broxo-Dent was brought to the 
U.S. by Squibb five years later, maintaining its place 
in the electric toothbrush market through the 1980s. 
Meanwhile, GE had tried out a bulky nickel cadmium 
battery version, and when safety regulators began to balk 
at the bathroom AC cord in the 1990s, smaller, sleeker 
battery-driven models gained momentum.
But Americans -- indeed most cultures familiar with 
oral hygiene -- were used to having their own toothbrush. 
With the price of a single electric unit out of reach for 
many consumers, the idea of multiple rechargeable 
toothbrushes in a given household was a non-starter, 
whatever their potential health benefits.
Nottingham and Spirk decided to change that with 
low-cost production, a simple oscillating head, standard 
AAA batteries, and an aggressive promotional campaign. 
Over the next decade, electric toothbrushes grew to more 
than 30 percent of the oral hygeine market. Proctor & 
Gamble later sold Spinbrush to Arm & Hammer, where 
the brand now includes toothbrushes that reciprocate at 
much higher speeds than standard electric models, and 
at much lower cost than expensive “sonic” toothbrushes.
They’ll have plenty more opportunities of their own. 
At last count, Nottingham Spirk was responsible for 
over 900 commercial patents worldwide, with many 
more ideas in the works.
Messrs. Nottingham and Spirk received engraved 
plaques in recognition of the Ohio Patent Impact Award 
at the academy’s annual meeting on April 14, 2012 at 
Ashland University. A panel of five members from 
the academy’s Board of Trustees and the Intellectual 
Property Law Section of OSBA reviewed their work 
among 13 nominations for the Ohio Patent Awards, 
which also include the 2012 Legacy Award. Nominees 
were judged by several criteria, including (a) largest 
number of patents in a single year, or (b) a patent that 
has contributed to Ohio’s economy, workforce, social 
welfare, health status, or other concerns.
The two inventors met in their formative years at 
the Industrial Design Department of the Cleveland 
Institute of Art, where they were reputed to be the star 
pupils of artist, ceramist, and industrial designer Viktor 
Schreckengost, regarded by many as the founder of 
industrial education in the U.S. Nottingham and Spirk 
received offers from Fortune 500 companies upon 
graduation but chose to start their own design firm by 
the same name in 1972. They have been at it ever since.
Inventors John R. Nottingham and John W. Spirk
Nottingham Spirk Design Associates
2200 Overlook Road
Cleveland, OH 44106-2326
216.231.7830
jnottingham@nottinghamspirk.com
jspirk@nottinghamspirk.com
Attorney Patrick Roche
Fay Sharpe LLP
The Halle Building
1228 Euclid Ave., 5th Floor
Cleveland, OH 44115-1834
216.363.9000
proche@faysharpe.com
STIRLIng CyCLE TypE THERmaL DEvICE 
USP 3,552,120; Jan. 5, 1971; William T. Beale
Patent Abstract  
A Stirling cycle thermal engine or refrigerating device 
wherein there is no primary mechanical connection between 
the displacer pistons and their associated power pistons, 
including various mechanical and pressure fluid means for 
varying the power output from or the power input to the device. 
William T. Beale
2012 Ohio Patent Legacy Award
A half century ago an engineering professor and full-time tinkerer tossed aside his crankshaft and his university job to create 
a better Stirling engine—a hot and cold idea that had 
rattled around since the early 1800s, when it took its 
name from a forward-thinking Scottish minister. The 
external combustion “air” piston would give way to steam 
power and then internal combustion engines, reemerging 
over a century later as the “free-piston” design of Mr. 
William T. Beale.
His “eureka” moment at Ohio University in 1964, 
when he realized the dormant Stirling concept could 
do without the traditional drive mechanism and its 
lubrication problems, led to a U.S. patent in 1971, the 
formation of Athens-based Sunpower, Inc. in 1974, 
and his selection for the Ohio Academy of Science and 
the Ohio State Bar Association’s (OSBA) Ohio Patent 
Legacy Award in 2012.
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The closed-cylinder design conceived by Rev. Dr. 
Robert Stirling in 1816 was not prone to the high-
pressure explosions of early steam engines and offered 
improved efficiency over older hot air designs. His 
included the traditional power piston and passive 
“displacer” piston, which moves the alternatively 
cooling/expanding gas back and forth between hot 
and cold chambers. It also included his patented “Heat 
Economizer”—a regenerator by any other name—which 
provided much better thermal exchange: the foundation 
of the external combustion air engine.
But the limited power range of the Stirling engine 
still required high temperatures that led to mechanical 
failures. It was ultimately supplanted by its external 
combustion cousin, the steam engine, which in turn 
yielded to electric motors and internal combustion 
engines.
The air engine eked out a living as a water pump and 
a few other domestic implements until Phillips began 
fiddling with a portable radio and a Stirling generator 
in the 1930s powered, of all things, by lamp oil. After 
two decades of development, however, the company 
decided its air engine was too unwieldy for commercial 
production.
“Too heavy, too complicated, too slow to respond, and 
way too expensive,” says Beale. Low-powered transistor 
radios had done them in.
Phillips’ research would continue into the 1970s 
with hundreds of millions of dollars spent on a failed 
automotive program, which the Stirling has still to 
see on a commercial scale. The company wanted to 
tap the engine’s potential with better manufacturing 
processes and materials—a goal that had taken a major 
leap forward with Prof. Beale’s free piston design. He 
was lecturing on the “rhombic” Stirling, which got by 
without pivoting connecting rods but retained a crank 
and double flywheels, when he realized, “This engine 
will still run if we simply throw away this complex drive 
mechanism,” according to Ohio University lore. 
“All of sudden, I got rid of half the cost. I also got rid 
of the slow response,” Beale says. 
 Instead of driving a mechanical crank, the fixed 
connecting rod could operate an inline generator or 
pump at higher temperatures and higher pressure, 
without lubrication. Using hydrogen or other suitable 
gases, a typical temperature range between cold and 
hot ends of the cylinder would be 100–1000 degrees 
Fahrenheit.
As a co-generator or heat pump, the free-piston 
Stirling has many possible applications, he says, including 
solar-powered air conditioners, cryogenic coolers, 
efficient gas-fired refrigerators and home heating systems, 
and yes, cars.
“Some of the most important automotive 
manufacturers came around to look at what we were 
doing at OU,” says Beale. “The engineers loved it. The 
business guys who make the decisions said, ‘We’re making 
money now.’”
Sunpower has drawn renewed interest from the auto 
industry in the past year, however, and engineers say the 
economics are catching up with the technology.
“It will easily beat the diesel in cost,” they tell him, 
which could include cars powered partly by sun. “A 
solar sterling engine can beat a photovoltaic cell by a 
large margin,” says Beale.
He says the U.S. is already behind much of the rest of 
the industrialized world when it comes to energy policy.
”We’re just backward on energy compared to the 
Europeans,” Beale says of the Stirling’s cogeneration 
potential. “It’s two or three times as efficient in heating 
a house as a gas furnace.”
With NASA employing the air engine as a cryogenic 
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cooler and a deep space generator for many years, he says 
the science is sound and the economics of the Stirling 
more competitive than ever.
Mr. Beale received an engraved plaque acknowledging 
his Ohio Patent Legacy Award from Dr. Jimmy Tong, 
Academy past-president. Five panel members from the 
academy’s Board of Trustees and the Intellectual Property 
Law Section of OSBA judged Mr. Beale’s work among 
13 nominations for the Ohio Patent Awards, which 
also include the 2012 Impact Award. Applications 
were judged by several criteria, including (a) largest 
number of patents in a single year, or (b) a patent 
that has contributed to Ohio’s economy, workforce, 
social welfare, health status, or other concerns. 
   A World War II veteran, Mr. Beale obtained his 
bachelor’s degree on the G.I. Bill and later earned 
master’s degrees from both MIT and Cal Tech, where 
he secured a full-ride scholarship on the strength of 
his undergraduate performance. He went on to work 
for NASA in Cleveland before accompanying his wife 
during her studies at Cambridge University. Returning 
stateside, he applied for several faculty positions and 
eventually accepted the post at Ohio University, where 
Beale began his journey with the Stirling engine.
Inventor Mr. William T. Beale
Sunpower, Inc.
1055 East State St., Ste. D
Athens, Ohio 45701-7911
740.594.2221
rennich@sunpower.com
THERmOpLaSTIC ELaSTOmERS 
Of ISOBUTyLEnE anD pROCESS Of 
pREpaRaTIOn
USP 34,640 (formerly 4,946,899); June 14, 1994; Kennedy, 
Puskas, Kaszas and Hager
Patent Abstract
Block copolymers compose a polyisobutylene rubbery soft 
segment of M, of about 5,000 to above 500,000 and glassy 
hard segments of M.sub.n of about 5,000 or higher and usually 
about 10,000 to 35,000 or more, are made by preparing a living 
polymer block of the polyisobutylene and then polymerizing 
on said living polyisobutylene block the glassy hard segments 
by adding thereto an electron donor having a donor number 
of 15 to 50 and then adding and polymerizing the monomers 
for the glassy hard segments. The monomers for the glassy 
hard segments are styrene and its derivatives and indene and 
its derivatives and mixtures thereof.
Dist. Prof. Joseph P. Kennedy 
and Attorney Ray. L. Weber 
2011 Ohio Patent Legacy Award 
Complex chemistry, rewarding years of polymer research. For heart patients, a simple chance at life. The 2011 Ohio Patent Legacy 
Award celebrates an impressive run of 107 U.S. patents 
marked by the discovery of a chemical process that 
joins rubbery and heat-sensitive polymers in a unique 
solution to the biotechnological challenges of coronary 
artery stents -- only one of the medical and industrial 
uses credited to the 1994 patent of Dist. Prof.  Joseph P. 
Kennedy of the Goodyear Polymer Center at University 
of Akron. The joint award of the Ohio Academy of 
Science and the Ohio State Bar Association’s Intellectual 
Property Law Section also recognizes Dr. Kennedy’s legal 
counsel, Ray L. Weber of Renner Kenner Intellectual 
Property Law in Akron.
Dr. Kennedy’s invention built on decades of work 
with polyisobutylene (PIB), the primary rubber material 
used in party balloons, adhesives, and tire linings. 
More than 60 years after its development in the 1930s, 
the Hungarian native discovered that cross-linking or 
bonding isobutylene with styrene produces the co-
polymer styrene-isobutylene-styrene (SIBS), which is 
very compatible with the human body. So-called in vivo 
devices, such as those made possible by the polymer, help 
people with a range of medical conditions live longer, 
healthier, and more productive lives.
Carbocationic polymerization, as it’s called, can 
be used to produce “block” polymer chains with the 
elasticity of rubber and the heat sensitivity of plastic. 
They become softer at higher temperatures and harder 
at lower temperatures, returning to the consistency of 
vulcanized rubber without the required chemical and 
heat curing. This imparts a similar strength and stability 
to adhesives, threads, coatings, and other products that 
are not good candidates for vulcanization.
Boston Scientific Corporation has taken advantage of 
those properties to produce the TRANSLUTE® polymer 
coating for its TAXUS® coronary stents, which are based 
on Dr. Kennedy’s invention. Unlike bare metal stents, 
they are permeable and allow for the controlled release of 
medications to slow the build-up of platelets that narrow 
the arteries -- the hallmark of coronary artery disease.
Today, an estimated six million heart patients owe their 
quality of life to Dr. Kennedy’s co-polymer research. Its 
application to drug-eluting stents has produced revenues 
exceeding $1 billion.
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Mr. Weber and Dr. Kennedy received two engraved 
plaques in recognition of the Ohio Patent Legacy Award 
at the academy’s annual meeting on April 16, 2011 at 
Otterbein University. A panel of five members from 
the Academy’s Board of Trustees and the Intellectual 
Property Law Section of OSBA evaluated their work 
among 13 nominations for the Ohio Patent Awards, 
which also include the 2011 Impact Award. (See below.) 
Applications were judged by several criteria, including (a) 
largest number of patents in a single year, or (b) a patent 
that has contributed to Ohio’s economy, workforce, 
social welfare, health status, or other concerns. Nominees 
together represent more than 480 patents and millions 
of dollars in sales for Ohio businesses.
Dr. Kennedy earned his B.S. in chemistry at University 
of Budapest in 1948 and his PhD in bio-chemistry at 
University of Vienna in 1954 before post-doctoral work 
at Sorbonne University in Paris and McGill University 
in Montreal. He began full-time academic research 
at UA in 1970 after 14 years in the business world at 
Celanese Corp. and Exxon Research and Engineering 
Co., becoming the university’s distinguished professor 
of polymer science and chemistry in 1980. By then, he 
had already secured over 30 U.S. patents, starting with 
his first in 1967. His most prolific period yielded eight 
patents in 1990, followed several years later by the co-
polymer discovery. Its use in life-changing coronary 
stents also won Kennedy a second honor in 2011: the 
American Heart Association’s Heart Champion Award.
Inventor Dist. Prof. Joseph P. Kennedy
The University of Akron
Goodyear Polymer Center
170 University Avenue
Akron, Ohio  44325-0044
330.972.7512
josep19@uakron.edu
Attorney Ray L. Weber
Renner Kenner Intellectual Property Law
First National Tower
106 S. Main St., Fourth Floor
Akron, Ohio 44308-1431
330.376.1242
iplaw@rennerkenner.com
gROwTH HORmOnE anTagOnISTS
USP 5,350,836; Sep.27, 1994; John Kopchick, Wen Y. Chen
Patent Abstract
The present invention relates to antagonists of vertebrate growth 
hormones obtained by mutation of the third alpha helix of such proteins 
(especially bovine or human GHs). These mutants have growth inhibitory or 
other GH-antagonizing effects. These novel hormones may be administered 
exogenously to animals, or transgenic animals may be made that express 
the antagonist. Animals have been made which exhibited a reduced growth 
phenotype.
Prof. John Kopchick
2012 Ohio Patent Impact Award
A genetic discovery that blocks growth hormone linked to rare childhood “gigantism” may 
one day benefit a much larger population afflicted with 
breast and prostate cancer.
Human growth hormone (GH), or somatropin, has 
191 amino acids. The mutation of a single one retards 
instead of spurs growth, resulting in a unique treatment 
for persons battling acromegaly, or “large extremities.” 
The invention has earned Ohio University Prof. John 
Kopchick the Ohio Academy of Science’s 2012 Ohio 
Patent Impact Award and the university’s Edison 
Biotechnology Institute more than $73.5 million in 
royalty income from Pfizer Inc., which markets the drug 
Somavert as an alternative treatment for acromegaly.
Kopchick, a plain-spoken man with an extraordinary 
history of patented research, has been Ohio University’s 
(OU) Goll Ohio professor of molecular and cellular 
biology since 1987. He arrived at the university that 
year and quickly discovered the gene mutation with the 
assistance of graduate student Wen Chen.
“We were working on the growth hormone to come up 
with a more potent molecule to treat dwarfism. Instead, 
we found something to treat acromegaly,” Kopchick says.
The discovery was granted a U.S. patent in 1994 and 
approved by the U.S. Food and Drug Administration 
in 2003 after 15 years of research and clinical trials. 
The tens of millions of dollars his invention has 
brought the university are largely responsible for OU’s 
national fourth-place ranking for “return on research 
investment,” says Director David Wight of the Edison 
Biotechnology Institute (EDI). The university is the 
top royalty producing institution in Ohio.
Acromegaly, whose juvenile-onset form is seen in 
Andre the Giant, “Jaws” (Richard Kiel) of James Bond 
fame, and even, according to speculation, President 
Abraham Lincoln, is caused in nine out of 10 cases 
by a benign tumor of the pituitary gland. This type of 
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adenoma, and thus gigantism or adult-onset acromegaly 
itself, is believed to be an environmental condition rather 
than an inherited gene trait.
“If a child has this tumor, and it’s untreated, that person 
will grow up to be a giant,” says Kopchick, noting that 
the pituitary tumor appears more frequently in adults. 
They do not develop unusual height but can experience 
enlargement of the hands and feet, facial disfiguration, 
throat problems that can lead to apnea, and organ 
disorders that can lead to death.
By blocking excess growth hormone in adults 
or children, pegvisomant—the chemical name for 
Somavert—is helping individuals suffering from 
acromegaly live more normal lives, Kopchick says.
“It’s used all over the world -- I would say three fourths 
of it outside the U.S.,” he says of the tens of thousands 
of individuals diagnosed with gigantism and adult 
adenomas.
Kopchick says ongoing research suggests the GH 
inhibitor could also treat a far more pervasive problem. 
He is currently an advisor for human clinical trials on 
use of the gene mutation in breast and prostate cancer 
patients.
He is careful to note, however, that the GH inhibitor 
is not a type of a gene therapy, which has yet to be 
approved in the United States in any form.
Buried in his 30-page patent, however, is a quiet 
acknowledgement of the drug’s potential: “Conceivably, 
a mammal could be genetically modified after birth, i.e., 
‘gene therapy.’”
The immediate outcome in someone not suffering 
from acromegaly, however, would be dwarfism -- as 
Prof. Kopchick notes, hardly a goal of growth hormone 
research.
Beyond the 15 U.S. patents and five pending patents 
he currently holds, his ongoing work is instead focused 
on the role of human growth hormone in aging and the 
identification of genes involved in diabetes, obesity, and 
aging, among other challenges in molecular biology
Prof. Kopchick received his bachelor’s of science 
degree in biology from the  Indiana University of 
Pennsylvania (IUP) in 1972, a master’s of science degree 
in biology and chemistry from IUP in 1975, and a Ph.D. 
in virology and biomedical sciences from the University 
of Texas - MD Anderson Hospital, Houston in 1980. 
He was a postdoctoral fellow for Roche Institute of 
Molecular Biology in Nutley, NJ from 1980 to 1982 and 
a research fellow at the Merck Institute of Therapeutic 
Research in Rahway, NJ from 1982 to 1986. While 
there, he developed a system for cloning human growth 
hormone. In addition to his 26 years as Goll professor 
of molecular and cellular biology at OU’s Department 
of Biological Sciences, he has also been director of EBI’s 
Growth, Diabetes and Obesity Section since 1987.
Inventor Prof. John J. Kopchick
Ohio University
Edison Biotechnology Institute
Building 25, The Ridges
Athens, Ohio 45701
740.592.5221
kopchick@ohio.edu
MeTHOD AND APPARATUS fOR DeTecTING 
PHycOcyANIN-PIGMeNTeD ALGAe AND 
BAcTeRIA fROM RefLecTeD LIGHT 
USP 7,132,254; Nov. 7, 2006; Robert K. Vincent 
Patent Abstract
The present invention relates to a method of detecting 
phycocyanin algae or bacteria in water from reflected light, 
and also includes devices for the measurement, calculation 
and transmission of data relating to that method.
Prof. Robert K. Vincent 
and Attorney Roger A. Gilcrest 
2011 Ohio Patent Impact Award
Local news coverage has familiarized most Ohioans with the blue-green algae, as it’s popularly known, which can restrict lake and 
river recreation and threaten drinking water. Fewer 
know of the satellite imaging technology that now 
allows authorities to quickly detect the growth of algal 
“blooms” and warn communities against toxic exposure.
A mathematical algorithm that measures the presence 
of the algae by analyzing reflected light—the larger field 
of spectroscopy—won Bowling Green State University 
(BGSU) a U.S. patent in 2006 and geology Prof. Robert 
K. Vincent primary credit as its inventor. The Ohio 
Academy of Science and the Ohio State Bar Association’s 
(OSBA) Intellectual Property Law Section followed 
by honoring Dr. Vincent and his attorney, Roger A. 
Gilcrest, formerly of Scholtenstein, Zox & Dunn, with 
the 2011 Ohio Patent Impact Award.
Algae, or more properly, bacteria rich in phycocyanin 
(“cyan” being derived from the ancient Greek word for 
blue), was a problem in Lake Erie decades ago and saw 
a resurgence there and in other parts of the U.S. in the 
mid-late 1990s. Older types of detergent containing 
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phosphorus had multiplied cyanobacteria through 
human waste water. 
“Now the phosphorous is coming back for different 
reasons,” says Dr. Vincent, laying major blame on 
fertilizers that run off from farms into Lake Erie and 
other bodies of water. But he says there is another cause.
“Global warming seems to be adding to cyanobacteria. 
Lake Erie is not freezing as much as it used to,” Dr. 
Vincent says, suggesting more C02 in the atmosphere 
is also making the lake more acidic—a favorable 
environment for cyanobacteria.
The thick scum covering large areas of Lake Erie during 
parts of the year has spurred research at the Geology 
Department of BGSU, not far from the Western Basin 
where the bacteria has seen some its worst outbreaks.
Though not algae, the waterborne microbe is often 
referred to as such because of its appearance and ability 
to photosynthesize food. Far more ancient than its Greek 
name, it is credited with the oxygenation of Earth’s 
atmosphere billions of years ago, making it one of the 
planet’s oldest fossils. The curiosity is that bacteria which 
can threaten fish, birds, and various mammals also made 
it possible for humans and other animals to live.
Toxins present in some cyanobacteria, called 
microcystin, are linked to health problems as minor 
as skin, stomach, and eye irritations, and as serious as 
Parkinson’s, Lou Gehrig’s, and Alzheimer’s disease, along 
with certain kinds of tumors.
“The World Health Organization has a standard 
that’s pretty much accepted,” says Dr. Vincent. “It says 
you should not drink water with one part per billion of 
microcystin or engage in recreation around water with 
20 parts per billion.”
He says a toxicologist at BGSU assisted him in 
evaluating the presence of cyanobacteria and microcystin 
at Port Clinton.
“It was 50 parts per billion, and people were swimming 
in it,” he says.
In 2003, Dr. Vincent published preliminary results 
of his Landsat research that showed satellite data can 
be used to accurately map the growth of algal blooms. 
By 2006, he had confirmed his findings and secured 
BGSU a patent for use of spectral imaging to measure 
cyanobacteria colonies in their infancy.
This is possible because the phycocyanin pigment 
gathers light through photosynthesis, producing 
what Dr. Vincent calls its own “spectral signature.” 
The advantage to scientists and health authorities, 
previously limited to more direct methods of observing 
and measuring cyanobacteria in water, is that mapping 
can now be done quickly and remotely. This allows the 
public to be warned and those responsible for water 
conditions to take corrective action.
The benefit can also be measured in tax dollars. In the 
case of public reservoirs, remote imaging of cyanobacteria 
can lower the cost of water sampling from $375 per 0.2 
acres to less than $2 -- a 200 percent reduction. With 
more than 150 drinking water reservoirs in Ohio and 
more than 11,000 of them in the U.S., the savings—and 
the business potential—are real. 
Recognizing its practical and commercial uses, Dr. 
Vincent co-founded Blue Water Satellite, Inc. in 2008 
while remaining a full-time faculty member at BGSU. 
He got some help from the state’s private development 
initiative, JobsOhio, and its northwest Ohio partner, 
Regional Growth Partnership, which awarded Blue 
Water the funding to perform its first market analysis. 
Blue Water’s clients now include the U.S. Army Corps 
of Engineers, the National Oceanic and Atmospheric 
Administration, Pacific Gas and Electric, and other 
private and public entities.
The technology currently has a margin of error of 
plus or minus 10 percent. But Dr. Vincent says he’s 
developing a new satellite algorithm to better measure 
not only the presence of cyanobacteria, but also the 
concentration of microcystin.
“I would like people to be able to look at a website 
and decide whether they want to go to this lake or that 
lake,” he says.
While health and environmental concerns have driven 
blue algae detection, Dr. Vincent says there is virtually 
no end to the chemicals that can be measured by remote 
satellite imaging.
“This is a precursor to our mapping the chemistry 
of water, of land, and of biological forms,” he says of 
earth-based spectroscopy.
The academy and OSBA presented the Ohio Patent 
Impact Award to Dr. Vincent and Mr. Gilcrest on 
April 16, 2011 at the academy’s annual meeting, held at 
Otterbein University. Five panelists from the academy’s 
Board of Trustees and OSBA’s Intellectual Property Law 
Section of reviewed their work among 13 nominations 
for the Ohio Patent Awards, which also include the 2011 
Legacy Award. (See above.) Applications were judged by 
several criteria, including (a) largest number of patents 
in a single year, or (b) a patent that has contributed to 
Ohio’s economy, workforce, social welfare, health status, 
or other concerns. Nominees have together produced 
more than 480 patents and millions of dollars in sales 
for Ohio businesses.
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Dr. Vincent earned a PhD in geology from University 
of Michigan in 1973, a master’s of science in physics 
from the University of Maryland in 1966, and bachelor’s 
degrees in physics and mathematics from Louisiana Tech 
University in 1963. After completing his doctorate, he 
founded and ran GeoSpectra Corporation for 19 years 
before joining BGSU as associate professor. He now 
holds the title of emeritus professor of geology.
Inventor Prof. Emeritus Robert K. Vincent
Bowling Green State University
Department of Geology
190 Overman Hall
Bowling Green, Ohio 43403-0211
419.372.0160
rvincen@bgsu.edu
Attorney Roger A. Gilcrest
Ice Miller LLP [Schottenstein Zox and Dunn Co.,  
 LPA at time of patent; later merged with Ice  
 Miller]
250 West St., Ste. 500
Columbus, Ohio 43215-7509
614.462.1055
roger.gilcrest@icemiller.com
Ohio Patent Awards 2015
Check “Awards” at www.ohiosci.org or see application: 
www.ohiosci.org/PatentAward.pdf
Purpose
The purpose of The Ohio Academy of Science Patent Awards is to recognize individuals, organizations, institutions 
and corporations who have contributed 
significant intellectual property in the form of 
a granted patent within the geographical state 
of Ohio. Ohio has a rich history of innovation 
including the controlled, powered airplane, the 
automobile self-starter, the flip top can, the vaccine 
for feline leukemia, and numerous other patented 
inventions which have had a worldwide impact. 
123rd Annual Meeting
The OhiO AcAdemy of Science
April 5, 2014
Hosted by Walsh University
North Canton, Ohio
THEME: Encouraging Tomorrow’s Innovators
Watch for details at www.ohiosci.org
